Science Translational Medicine · 2021 · 100 citations · 47 references
MedicineCell BiologyDermatologyImmunopathologyImmunoregulationInflammationImmunopathology Of SkinScar FormationScar ManagementSkin RegenerationSkin RejuvenationC-jun N-terminal Kinase SignalingFibroblast ActivationHypertrophic Scar TreatmentJun N-terminal Kinase SignalingScar BiologyScar Pathophysiology
. Blocking CD36 with salvianolic acid B or CD36 knockout model counteracted JUN-mediated fibrosis efficacy in both human fibroblasts and mouse wounds. In summary, JUN is a critical regulator of pathological skin scarring, and targeting its downstream effector CD36 may represent a therapeutic strategy against scarring.
47
GREAT improves functional interpretation of cis-regulatory regions
Cory Y. McLean, Dave Bristor, Michael Hiller et al. · Nature Biotechnology · 2010 · 5K citations